Bemotrizinol Sunscreen: What It Means for U.S. Skin Care

Medically reviewed by the HyaluFlow Health Editorial Team | Published: August 8, 2026 | Last Updated: August 8, 2026

Quick Answer

Bemotrizinol is a modern broad-spectrum sunscreen filter that absorbs both UVA and UVB radiation.

In June 2026, the U.S. Food and Drug Administration added bemotrizinol to the U.S. OTC sunscreen monograph. This gives American sunscreen manufacturers another option for formulating broad-spectrum products. [1,2]

The ingredient is not brand new. It has been used internationally for years. What is new is its permitted use under the U.S. OTC sunscreen system.

Key Takeaways

• Bemotrizinol is a broad-spectrum organic UV filter.
• It absorbs both UVA and UVB radiation.
• The FDA added it to the U.S. OTC sunscreen monograph in 2026.
• The final order permits concentrations up to 6% under specified conditions. [2]
• Bemotrizinol is highly photostable.
• It may help reduce UV exposure linked to photoaging.
• It does not erase wrinkles or rebuild damaged collagen.
• It does not make existing sunscreen filters obsolete.

What Is Bemotrizinol?

Bemotrizinol is an organic sunscreen filter that absorbs ultraviolet radiation.

It is also known as BEMT. The ingredient has been used in sunscreen products outside the United States for many years.

Its broad absorption profile covers important portions of the UVA and UVB ranges. That makes it useful when formulators are building broad-spectrum sunscreen products. [1,3]

That distinction matters because UVA and UVB affect skin differently.

UVB is strongly associated with sunburn and contributes to skin cancer risk. UVA penetrates deeper into the skin and contributes to photoaging and pigmentation.

Why Is Bemotrizinol a Big Deal in the U.S.?

The biggest story is not that scientists suddenly discovered a new sunscreen ingredient.

It is that the U.S. sunscreen market now has another modern UV filter available under the OTC monograph.

In June 2026, the FDA added bemotrizinol to the U.S. OTC sunscreen monograph. The agency described it as the first new sunscreen active ingredient added to the monograph since the late 1990s. [1]

The final administrative order permits bemotrizinol at concentrations up to 6% under specified conditions. It has an effective date of August 9, 2026, subject to the applicable federal process. [2]

Bemotrizinol is not a magic new anti-aging ingredient. Its importance is that U.S. sunscreen formulators now have another modern broad-spectrum UV filter to work with.

How Does Bemotrizinol Protect Skin?

Bemotrizinol works by absorbing ultraviolet radiation before it can interact with skin tissue.

Its absorption extends across portions of both UVA and UVB wavelengths.

Another important property is photostability.

A photostable sunscreen filter maintains its chemical characteristics when exposed to sunlight. That is useful because sunscreen has to perform while sitting on sun-exposed skin.

Research on modern UV filters has identified photostability as an important characteristic of sunscreen performance. [3,4]

Can Bemotrizinol Slow Skin Aging?

Here is where the marketing needs to be separated from the science.

Bemotrizinol is not an anti-wrinkle treatment. It does not rebuild collagen or remove wrinkles that are already present.

Its potential anti-aging benefit is indirect.

Ultraviolet exposure contributes to collagen breakdown, elastin damage, pigmentation, and other changes associated with photoaging. Reducing UV exposure can therefore help prevent additional damage.

The FDA recognizes broad-spectrum sunscreen as part of a strategy to reduce sunburn, skin cancer risk, and early skin aging caused by the sun. [3]

So think prevention, not repair.

Is Bemotrizinol Safe?

The FDA reviewed available safety and effectiveness information before adding bemotrizinol to the OTC sunscreen monograph. [1,2]

The final order permits its use under specified conditions, including concentrations up to 6%.

Human pharmacokinetic research has also examined systemic exposure after repeated maximum-use application.

In a study using a 6% bemotrizinol formulation, systemic concentrations generally remained below the FDA threshold that triggers additional systemic safety studies. The researchers also found no evidence of accumulation above that threshold. [5]

These findings contributed to the regulatory safety assessment.

Still, no sunscreen ingredient should be described as completely risk-free. Product formulation and individual skin sensitivity also matter.

Will Bemotrizinol Replace Existing Sunscreens?

No.

Bemotrizinol gives manufacturers another tool. It does not make zinc oxide, titanium dioxide, or other established sunscreen filters useless.

Different UV filters absorb different parts of the spectrum and have different formulation properties.

Combining compatible filters can help manufacturers create broad-spectrum products with specific protection and cosmetic characteristics. The FDA's final order specifies conditions for combinations involving bemotrizinol. [2]

Bemotrizinol vs Mineral Sunscreens

There is no universal winner.

A bemotrizinol sunscreen may appeal to someone who prefers its formulation or cosmetic feel. A mineral sunscreen may be preferable for someone who specifically wants a mineral-filter product.

The better sunscreen is ultimately the one that provides appropriate broad-spectrum protection and that you will use consistently.

What Should You Do Now?

You do not need to throw away your current sunscreen.

If you already use a broad-spectrum sunscreen correctly, keep doing it.

When compliant bemotrizinol products become available in the U.S., they will simply give consumers another option.

Do not choose a sunscreen because an ingredient sounds futuristic.

Check the finished product's SPF, broad-spectrum labeling, formulation, skin compatibility, and whether you can comfortably use it every day.

Apply Sunscreen Consistently

Use broad-spectrum sunscreen on exposed skin according to the product directions.

Commonly missed areas include the ears, neck, hands, hairline, and upper chest.

Reapply When Needed

Swimming, sweating, and towel drying can reduce sunscreen coverage.

Follow the product's instructions for reapplication, especially during prolonged outdoor exposure.

Use Additional Sun Protection

Sunscreen is only one part of sun protection.

Shade, protective clothing, sunglasses, and reducing prolonged exposure during intense sunlight can further reduce UV exposure. The FDA recommends combining sunscreen with other protective measures. [3]

What the Science Says

The strongest evidence concerns what bemotrizinol is and how it behaves as a UV filter.

Its broad-spectrum absorption and photostability are well established. The FDA also reviewed safety and effectiveness information before adding it to the U.S. OTC sunscreen monograph. [1,2,4]

Evidence also supports low systemic exposure after maximum-use application of a 6% formulation. [5]

What the evidence does not show is that bemotrizinol independently reverses wrinkles, rebuilds collagen, or makes other sunscreen filters inferior.

Common Myths

Myth: Bemotrizinol was invented in 2026.

Fact: It is newly permitted under the U.S. OTC sunscreen monograph, but it has been used internationally for years. [1]

Myth: Bemotrizinol reverses wrinkles.

Fact: It is a UV filter. Its potential anti-aging benefit comes from preventing additional UV-related damage.

Myth: Bemotrizinol automatically means SPF 50.

Fact: SPF is determined by testing the finished sunscreen product, not by one ingredient alone.

Myth: Bemotrizinol makes mineral sunscreen obsolete.

Fact: Mineral filters remain useful. Bemotrizinol simply expands the available options.

Who Should Pay Attention?

Bemotrizinol is worth watching if you care about sunscreen technology, photoaging prevention, or the expanding range of UV filters available in the United States.

It may eventually give consumers more choices in sunscreen texture and formulation.

But there is no reason to wait for it. Existing broad-spectrum sunscreens can provide meaningful UV protection when used properly.

Evidence Strength Summary

Bottom Line

Bemotrizinol is a meaningful development for the U.S. sunscreen market.

It is a modern broad-spectrum UV filter with high photostability and years of international use.

The FDA's 2026 decision gives U.S. manufacturers another option for developing sunscreen products. [1,2]

But the hype should stay in check.

Bemotrizinol does not erase wrinkles, rebuild damaged collagen, or make every other sunscreen ingredient obsolete.

Its real value is simpler: helping protect skin from UVA and UVB exposure.

For healthier skin over time, consistent broad-spectrum sun protection still matters far more than chasing the newest ingredient.

Medical References

1. U.S. Food and Drug Administration. FDA Expands Sunscreen Options for the First Time in 20 Years. June 9, 2026.
2. U.S. Food and Drug Administration. Final Administrative Order OTC000039: Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use. June 2026.
3. U.S. Food and Drug Administration. Sunscreen: How to Help Protect Your Skin from the Sun.
4. Gomes JVT, et al. Molecular modeling as a design tool for sunscreen candidates: a case study of bemotrizinol. Journal of Molecular Modeling. 2020;26:21. PMID: 31773345.
5. D'Ruiz CD, et al. Preliminary clinical pharmacokinetic evaluation of bemotrizinol: A new sunscreen active ingredient being considered for inclusion under FDA's OTC sunscreen monograph. Regulatory Toxicology and Pharmacology. 2023;138:105344. PMID: 36738872.